IRIS
VARNIER, OLIVIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.324
Totale 9.324
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 9.324
Totale 9.324
Salva come PNG Salva come JPEG
Città #
Genova 6.931
Rapallo 1.202
Genoa 702
Vado Ligure 472
Bordighera 17
Totale 9.324
Salva come PNG Salva come JPEG
Nome #
Use of an atmospheric simulation chamber for bioaerosol investigation: a feasibility study 176
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 149
A WEB tool for analysis of spectrophotometric data for the treatment of patients with HIV 141
A NOVEL AND INNOVATIVE QUANTITATIVE KINETIC SOFTWARE FOR VIROLOGICAL COLORIMETRIC ASSAYS. 131
First report of the presence of Human T-Cell Lymphotropic Virus I infection in Italian drug addicts. 131
Coumermycin inhibition of murine retrovirus replication in cultured cells. 131
Infection of rabbits with human immunodeficiency virus. 127
Analysis of HTLV-I env gene sequence from an Italian polytransfused patient: evidence for a Zairian HTLV-I in Sicily. 127
HIV-1 and HIV-2 seroprevalence in tuberculosis patients in Guinea Bissau. 126
A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies 124
CLINICAL RELEVANCE OF ICD P24 VERSUS CD4 COUNT FLUCTUATIONS IN PATIENTS UNDERGOING ANTIRETROVIRAL THERAPY 122
A fatal case of streptococcal and meningococcal meningitis in a 2-years-old child occurring as Waterhouse-Friderichsen Syndrome. 117
Infections in patients with febrile neutropenia: epidemiology, microbiology and risk stratification 116
Unsung hero Robert C. Gallo 114
Virology laboratory automation: a user friendly database 113
Perinatal transmission of HIV-2 infection in malnourisched children in Guinea Bissau. 112
Differential effect of dexamethasone on replication of ecotropic and xenotropic mouse type C viruses. 112
A qualitative process theory based model of the HIV-1 virus-cell interaction 112
Fibrin clot retractile activity in normal, established and tumorigenic human epithelial cells in culture. 111
Murine xenotropic type C viruses. V. Biologic and structural differences among three cloned retroviruses isolated from kidney cells from one NZB mouse. 110
Host range differences among xenotropic type C retroviruses isolated from mouse kidney cell cultures. 109
Automated collection of HIV-1 and HIV-2 antibody results from the labsystems multiskan mcc/340 109
Atypical Leishmaniasis in HIV-2 seropositive patient from Guinea-Bissau. 109
Single step PCR: A tool for molecular diagnosis of hepatitis C virus infection. 108
A case report of Absidia corymbifera soft-tissue infection with kidney involvement in a AIDS patient. 108
A Comparison of Two HIV RNA Surrogate Assays and Suggestion for Their Use in Monitoring HIV-Infected Patients in Resource-Limited Countries. 106
SEROEPIDEMIOLOGY OF THE HUMAN T CELL LEUKAEMIA LYMPHOMA VIRUSES IN EUROPE. 106
An integrated system for HIV Western Blot interpretation 103
HIV-1 RNA quantification by one-tube Q-NASBA in infected patients. 102
Detection of HIV-1 antibodies in blood specimens spotted on filter paper. 101
Current status of HIV-1 infection in the rabbit. 101
Quanti Aid (Win & Mac): a new software for the objective and quantitative reading of Genelabs HTLV blot 2.4 98
Improved detection of serum HIV p24 antigen after acid dissociation of immune complexes. 96
Intranet data connection for the follow-up of AIDS patients. 93
In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate. 93
Antiviral activity of Coumermycin: identification of resistant and sensitive retrovirus strains. 91
DETECTION OF HIV-1 SEQUENCES IN CHILDREN USING RADIOACTIVE AND COLORIMETRIC PCRS. 90
The first report of HTLV-I infection associated with blood transfusion in a thalassemic patient from Sicily (Italy) 90
Detection of HIV-1 proviral sequences in lymphocytes using a qualitative polymerase chain reaction assay 90
ArchAIDS: a data connection between a virology laboratory and a clinical department. 89
User friendly data base for automation in a virological laboratory 89
JCV-DNA testing during natalizumab treatment is complementary to anti-JCV antibodies for PML risk stratification 89
Whole blood collection on filter paper is an effective means of obtaining samples for Human Immunodeficiency Virus antibody. AIDS RESEARCH AND HUMAN RETROVIRUSES 4:131-136, 1988. 89
HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation. 88
Application of neural networks to the follow-up of AIDS patients. 88
A novel kinetic software detects high levels and flucuations of p24 antigenemia in AIDS patients and recandidates the p24 antigen as a surrogate marker for therapeutic response 88
Quanti-Kin Web: a web tool for p24 quantification 88
In vivo genetic variability of the HIV-2 V3 region 88
Drug resistance testing in PBMCs of HIV infected patients. 88
Level of Human Immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy 87
Accurate HIV-1 p24 antigen detection and use of a neural network in revealing clinical categories 85
ARCHAIDS CONNECTS A CLINICAL DEPARTMENT AND A VIROLOGICAL LABORATORY TO AUTOMATIZE THE FOLLOW UP OF AIDS PATIENTS 84
ArchAIDS connects a clinical department and a virological laboratory to automatize the follow up of AIDS patients. 84
Laboratory automation: the on going experience at the S. Luigi AIDS center at S. Raffaele hospital in Milan 84
RAPID AND ACCURATE QUANTIFICATION OF DIFFERENT HCV GENOTYPES BY LIGHTCYCLER REAT TIME PCR AND DIRECT SEQUENCING OG HCV AMPLICONS 82
Heat treatment, elast signal amplification and kinetic software recandidte the HIV-1 p24 antigen assay a marker of antiretroviral therapy efficacy 82
Stage-dependent induction of prenatal tumors in mice by the Kirsten and Moloney strains of murine sarcoma viruses 82
Therapy efficacy can be monitored by a sensitive and precise yet inexpensive HIV p24 antigen assay 81
Objective evaluation of two markers of HIV-1 infection (p24 antigen concentration and CD4+ cell counts) by a self organizing neural network. 81
Murine xenotropic type C viruses. I. Distribution and further characterization of the virus in NZB mice. 80
Sensitive micro in situ fluorescent focus assay for detection of murine xenotropic retroviruses 80
HTLV type IIIB infec tion of human thymic epithelial cells: viral expression correlates with the induction of NF-kB binding activity in cells activated by cell adesion. 80
A software tool to extend the quantification power of a virological analysis 80
Level of HIV DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy 80
Synthetic peptides in HIV antibody screening and typing. 80
DECAY OF HIV-1 2LTR DNA IN INFECTED INDIVIDUALS AFTER THREE TO EIGHT YEARS OF SUSTAINED CONTROL OF VIREMIA. 79
Laboratory automation: the on going experience at the S. Raffaele Hospital in Milan 79
New aspects and perspectives in AIDS diagnosis 79
Kinetic software detects p24 variations up to 7.000 pg/ml in AIDS patients 79
Virological markers in HIV-1 infected patients 79
HTLV SEROREACTIVITY IN ITALIAN INTRAVENOUS DRUG ADDICTS (IVDA) IS PRIMARILY DUE TO HTLV-II INFECTION 78
Rapid diagnosis of tuberculosis and multidrug resistance with the microscopic observation drug susceptibility assay in Ecuador. 78
The new HIV-1 p24 antigen 3 plus assay is a sensitive and inexpensive marker of viral load 78
A system for the control of data correctness and completeness in a data-base for the diagnosis of HIV-1/2 and other viral infections 78
Non invasive surveillance of JCV reactivation in blood and urine from natalizumab treated MS patients, blood donors and immunocompromised patients identifies two PML cases in HIV and congenital immunodeficiency patients 77
High levels and fluctuations of p24 antigenemia are quantifiable in AIDS patients using a novel kinetic software (QUANTI-KIN) 77
Quanti-Kin Web: a web tool for ELISA assay processing 76
HIV p24 antigen is recandidated as a sentinel marker of viral replication by an innovative and inexpensive assay 75
Kidney graft loss associated with JC polyomavirus associated nephropathy. 74
Parallel We-stern blot analysis for HIV-1 and HIV-2 antibodies: Absence of HIV-2 in-fection in Italian subjects at risk for AIDS. 74
The effect of treatment with zidovudine +/- acyclovir on human immunodeficieodeficiency virus p24 antigenaemia in patients with AIDS or AIDS related complex. 73
DYNAMICS OF HIV-1 VIRAL LOAD IN PREGNANCY. 72
Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA 72
Serological, biological and molecular characterization of New Zealand White rabbits infected by intraperitoneal inoculation with cell-free Human Immunodeficiency Virus. 71
HIV-1 p24 antigen fluctuations over 3 orders of magnitude revealed by a novel kinetic software (QUANTI-KIN) 70
High quantifiable levels of p24 antigenemia are detectable in HIV-1 infected patients 69
Novel kinetic quatification of HIV-1 p24 antigen with an extended range 68
Polyphenolic antioxisdant (-)-Epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. 68
Evidence for a 1980 HTLV-III infection in a currently asymptomatic B haemophiliac in Italy 66
Detection of HTLV-I and not HTLV-II infection in Guinea Bissau (West Africa). 66
HIV and HTLV infections in 1,305 thalassemics chronically transfused in Italy. 62
Unsupervised neural network as a tool for the3 objective evaluation of two markers of HIV-1 infection (p24 antigen and CD4+ cell) 61
Los niveles de DNA total de HIV en células mononucleares de sangre periférica (PBMC) correlan con la eficacia de la terapia antiretroviral 61
Phosphonoformate selective inhibition of murine retrovirus replication in vitro. 60
Quantification of proviral dna (viral burden) in HIV-1 patients treated with antiretroviral drugs 60
Heat treatment, elast signal amplification and kinetic software render the p24 antigen assay an alternative marker for AIDS patient management 57
Quantificazione del DNA provirale (carica virale) in pazienti con infezione da HIV-1 56
Presentazione della ricerca 56
Il trattamento al calore del campione, l'amplificazione del segnale con ELAST e il software di cinetica QUANTI-KIN ricandidano l'antigene HIV-1 p24 quale marker di efficacia terapeutica 55
Un esempio di automazione di laboratorio in paesi in via di sviluppo 51
Totale 9.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.520
article - articoli 18.128
book - libri 0
conference - conferenze 5.091
curatela - curatele 0
other - altro 717
patent - brevetti 0
selected - selezionate 0
volume - volumi 584
Totale 49.040
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.888 0 0 0 0 181 196 366 84 166 464 331 100
2020/2021406 26 22 42 24 15 56 22 26 55 29 42 47
2021/20221.091 14 91 107 121 48 72 65 280 20 93 33 147
2022/20231.431 146 79 35 167 195 273 3 93 196 3 221 20
2023/2024469 40 63 4 62 46 84 23 56 27 10 14 40
2024/2025493 33 147 50 106 157 0 0 0 0 0 0 0
Totale 9.348